The present invention is directed to novel compounds of Formula I pharmaceutically acceptable salts or solvates thereof, and their use.La présente invention concerne de nouveaux composés de formule (I), des sels ou solvates pharmaceutiquement acceptables de ceux-ci, et leur utilisation.